Renal Cell Carcinoma: Risk Stratification and Evolving Treatment Landscape
A panel of 4 experts on renal cell carcinoma introduce themselves and discuss IMDC risk stratification criteria and the evolution of the treatment landscape.
A panel of 4 experts on renal cell carcinoma introduce themselves and discuss IMDC risk stratification criteria and the evolution of the treatment landscape.
Tune in to hear Jarred Matchett, Chief Financial Officer of Fox Chase Cancer Center, as he shares insights into his background, successful strategies implemented…
Scientific publishing is a cornerstone of disseminating knowledge. One caveat of scientific publishing is that at any one time it is biased toward certain topics…
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
This inaugural report provides an overview of cancer occurrence, risk factors, and screening for disaggregated Asian American, Native Hawaiian and other Pacific Islander groups in…
Pasi A. Jänne, MD, PhD, of Dana-Farber Cancer Institute, discusses an exploratory analysis from the FLAURA2 study, which indicates that baseline levels of plasma EGFR…
In this episode of The Vitals, we speak with an expert who discussed the importance of supportive care and education for patients with lung cancer…
Educational resource providing health care professionals with the tools to aid in the diagnosis, treatment and management of Gastric Cancer.
A multipeptide vaccine combination approach with 12MP plus 6MHP vs 12MP plus tet extended overall survival in patients with stage IIB to IV melanoma.
Following the Ombudsman’s recent findings of maladministration regarding the Commission’s interactions with tobacco lobbyists
Volunteer for ASTRO Committee Service, Supervision work group, Fellows app due May 10